Mylan Laboratories Ltd Stock

Mylan Laboratories Limited is an India-based generics and specialty pharmaceutical company, which is engaged in manufacturing and marketing generic pharmaceuticals to retail, wholesale, government and institutional customers. The Company's product categories include human immunodeficiency virus (HIV) Care Products, Women's Care Products, Infertility Care Products, Onco Care Products and Critical Care Products. It offers a portfolio of antiretroviral (ARV) products for the treatment of HIV or acquired immunodeficiency syndrome (AIDS). In addition, it focuses on therapies, such as hormone replacement therapy (HRT). Its other product offerings include purified forms of follicle stimulating hormone, human menopausal gonadotropins, human chorionic gonadotropins, anti-fungal, antibiotic and anticoagulant therapies. It offers a portfolio of approximately 1,300 generic pharmaceuticals and several brand medications. It markets its products in approximately 140 countries and territories.